A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins

Tobias G Kapp1, Florian Rechenmacher1, Stefanie Neubauer1

  • 1Institute for Advanced Study and Center for Integrated Protein Science, Department of Chemistry, Technische Universität München, Lichtenbergstr. 4, 85747 Garching, Germany.

Scientific Reports
|January 12, 2017
PubMed

Insights

This study systematically compares integrin ligands, providing crucial data for selecting optimal RGD-binding integrin modulators for research and therapeutic applications.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Integrins are critical cell surface receptors regulating cell behavior.
  • Dysregulation of integrins is linked to various diseases.
  • Numerous integrin-specific ligands exist, but their reported affinities vary widely.

Purpose of the Study:

  • To systematically evaluate and compare the binding affinities of various ligands.
  • To assess ligand efficacy against specific RGD-binding integrins (αvβ3, αvβ5, αvβ6, αvβ8, α5β1, αIIbβ3).

Main Methods:

  • Utilized a homogenous ELISA-like solid phase binding assay.
  • Evaluated a broad spectrum of integrin-specific ligands.

Main Results:

  • Quantified binding affinities (IC50 values) for multiple ligands across several RGD-binding integrins.
  • Identified variations in ligand performance based on the specific integrin target.

Conclusions:

  • Provides a standardized comparison of integrin ligand binding affinities.
  • Offers essential data for informed selection of ligands in biomedical and biophysical research.
  • Highlights the need for consistent assay methodologies in ligand characterization.